Home › Stocks › DNLI › All Fund Holders
DNLI — DENALI THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 45 · Reported value held: $1.99B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 14.03M | $360.76M | 0.01% | Add |
| Baillie Gifford & Co history | Q2 2026 | 11.96M | $307.62M | 0.28% | Reduce |
| Vanguard Group history | Q4 2025 | 13.06M | $215.59M | 0.00% | Add |
| Temasek Holdings history | Q2 2026 | 7.01M | $180.37M | 0.51% | Hold |
| Fidelity Management & Research (FMR) history | Q2 2026 | 4.54M | $116.66M | 0.01% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 4.16M | $106.89M | 0.01% | Reduce |
| Geode Capital Management history | Q2 2026 | 3.97M | $102.21M | 0.01% | Add |
| UBS Group AG history | Q2 2026 | 3.12M | $80.26M | 0.01% | Add |
| Norges Bank Investment Management history | Q2 2026 | 2.82M | $72.65M | 0.01% | Reduce |
| Capital Research Global Investors history | Q2 2026 | 2.57M | $65.99M | 0.01% | Add |
| Casdin Capital history | Q2 2026 | 2.04M | $52.60M | 2.63% | Add |
| Principal Global Investors history | Q2 2026 | 1.42M | $36.52M | 0.02% | Reduce |
| Northern Trust Corp history | Q2 2026 | 1.39M | $35.74M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 1.24M | $32.02M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 1.23M | $31.66M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 1.13M | $28.95M | 0.01% | Reduce |
| Morgan Stanley history | Q2 2026 | 961.05K | $24.72M | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 800.28K | $20.58M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 600.07K | $15.43M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 549.83K | $14.14M | 0.01% | Reduce |
| Citigroup Inc history | Q2 2026 | 487.28K | $12.53M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 432.80K | $11.13M | 0.01% | Add |
| AQR Capital Management history | Q2 2026 | 388.47K | $9.99M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 343.90K | $8.85M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 287.02K | $7.59M | 0.00% | New |
| Two Sigma Investments history | Q4 2025 | 430.18K | $7.10M | 0.01% | Add |
| Wells Fargo & Co history | Q2 2026 | 189.87K | $4.88M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 149.80K | $3.85M | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 117.35K | $3.02M | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 111.95K | $2.88M | 0.00% | Add |
| Prudential Financial history | Q2 2026 | 58.13K | $1.50M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 56.66K | $1.46M | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 52.62K | $1.35M | 0.00% | Reduce |
| Polen Capital Management history | Q1 2026 | 65.30K | $1.25M | 0.01% | Add |
| Point72 Asset Management history | Q2 2026 | 46.40K | $1.19M | 0.00% | Add |
| Janus Henderson Group history | Q1 2026 | 60.03K | $1.15M | 0.00% | Hold |
| D. E. Shaw & Co history | Q1 2025 | 78.22K | $1.06M | 0.00% | New |
| Baron Funds history | Q1 2024 | 50.50K | $1.04M | 0.00% | Hold |
| Arrowstreet Capital history | Q3 2022 | 18.73K | $575.00K | 0.00% | New |
| Bridgewater Associates history | Q4 2022 | 14.97K | $416.32K | 0.00% | New |
| Amundi US history | Q1 2026 | 18.60K | $357.20K | 0.00% | New |
| PNC Financial Services history | Q2 2026 | 9.12K | $234.62K | 0.00% | Reduce |
| Renaissance Technologies history | Q4 2025 | 10.70K | $176.66K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 3.14M | $80.66K | 0.01% | Add |
| Lazard Asset Management history | Q1 2024 | 4.41K | $90 | 0.00% | Hold |